We are live on
!
Find out more
HFCIV
H&F Corporate Investors VIII Portfolio holdings
AUM
$133M
1-Year Est. Return
24.42%
This Fund
S&P 500
This Quarter
Est. Return
-10.33%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
–
AUM
$1.83B
AUM Growth
-$297M
(-14%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 55.23% |
| 2 | Technology | 44.77% |
Similar funds
NCTC
CWM
FFP
SI
DG
RHIG
VCM
DFG
H&F Corporate Investors VIII's Q1 2022 Portfolio in Review
As of Q1 2022, H&F Corporate Investors VIII held 2 positions worth $1.83B, down 14% from $2.12B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q1 2022: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 45% a quarter earlier, followed by Technology.
- H&F Corporate Investors VIII's ten largest holdings make up 100% of its $1.83B portfolio in Q1 2022.
- H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q1 2022.
- H&F Corporate Investors VIII's portfolio value fell 14% quarter-over-quarter to $1.83B.
Based on H&F Corporate Investors VIII's 13F filing for Q1 2022, filed 16 May 2022.